Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06244888 · ClinicalTrials.gov registry record · Phase 2
Control Systems Engineering for Weight Loss Maintenance
A Phase 2 study of Overweight and Obesity, sponsored by The Miriam Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06244888: Recruiting Phase 2 study of Overweight and Obesity, sponsored by The Miriam Hospital.
NCT06244888 is a Phase 2 study of Overweight and Obesity that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 180 participants, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06244888, a Phase 2 study of Overweight and Obesity, is actively recruiting participants, sponsored by The Miriam Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This project capitalizes on principles of control systems engineering to build a dynamical model that predicts weight change during weight loss maintenance using behavioral, psychosocial, and environmental indicators evaluated in a system identification experiment. A 6-month behavioral obesity treatment will be administered to produce weight loss. Participants losing at least 3% of initial body weight will be followed for an additional 12 months via daily smartphone surveys that incorporates passive sensing to objectively monitor key behaviors. Survey data pertaining to behavioral, psychosocial, and environmental indicators will be used to develop a controller algorithm that can predict when an individual is entering a heightened period of risk for regain and why risk is elevated. Interventions targeting key risk indicators will be randomly administered during the system ID experiment. Survey and passive sensing data documenting the effects of the interventions will likewise drive development of the controller algorithm, allowing it to determine which interventions are most likely to counter risk of regain.
Primary Outcome
This will be measured throughout the system identification experiment using a consumer scale with internet connectivity.
Conditions Studied
Interventions
- BEHAVIORAL Intervention Targeting Stress and Emotion Regulation
- BEHAVIORAL Intervention Targeting Motivation and Self-efficacy for Weight Management
- BEHAVIORAL Intervention for Normalization of Eating
- BEHAVIORAL Intervention Targeting Physical Activity and Sleep
Study Locations (1)
Rhode Island
- Miriam Hospital Weight Control and Diabetes Resarch Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 2 |
What NCT06244888 shows while recruiting
NCT06244888 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 4 interventions - of which Intervention Targeting Stress and Emotion Regulation is the first listed.
NCT06244888 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06244888 about?
NCT06244888 is a clinical study titled "Control Systems Engineering for Weight Loss Maintenance". This project capitalizes on principles of control systems engineering to build a dynamical model that predicts weight change during weight loss maintenance using behavioral, psychosocial, and environmental indicators evaluated in a system identification experiment. A 6-month behavioral obesity treat...
What is the current status of trial NCT06244888?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2024-02-26. Estimated completion is 2027-12-31.
What conditions does trial NCT06244888 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT06244888?
The interventions under investigation include: Intervention Targeting Stress and Emotion Regulation (BEHAVIORAL), Intervention Targeting Motivation and Self-efficacy for Weight Management (BEHAVIORAL), Intervention for Normalization of Eating (BEHAVIORAL), Intervention Targeting Physical Activity and Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT06244888?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06244888 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06244888's enrollment target sits among peer trials
180 35th of 115 higher than 80 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
RECRUITING · Phase 2
-
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
RECRUITING · Phase 2
-
Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers
COMPLETED · Phase 2
-
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI